Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | F7 | P08709 | 3/20 | 0.50 |
| ▸ | F3 | P13726 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1301319 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL4339464 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL4335893 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL5166020 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL8695877 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL25327373 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL80254 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL4341933 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL6438450 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL2931992 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116763963-A | Spiro compounds as malodor counteracting ingredients | 弗门尼舍有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-111432851-A | Use of volatile ingredients to limit or eliminate perception of malodour | 弗门尼舍有限公司 | 2020-07-17 | — | — | CN | claimed |
| CN-111295204-A | Spiro compounds as malodor counteracting ingredients | 弗门尼舍有限公司 | 2020-06-16 | — | — | CN | claimed |
| EP-2967033-A2 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | Stepan Company (US) | 2016-01-20 | — | — | EP | claimed |
| US-20160002571-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN CO (US) | 2016-01-07 | — | — | US | claimed |
| WO-2014164156-A2 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN COMPANY (US) | 2014-10-09 | — | — | WO | claimed |
| CN-122071575-A | Polycarbonate polyol, polyurethane, adhesive, paint, sealing material, aqueous polyurethane, water-dispersed composition and synthetic leather | 旭化成株式会社 | 2026-05-22 | — | — | CN | disclosed |
| CN-122071576-A | Polycarbonate polyol composition, adhesive composition, aqueous polyurethane, aqueous dispersion composition, polyurethane for synthetic leather, and synthetic leather | 旭化成株式会社 | 2026-05-22 | — | — | CN | disclosed |
| CN-118435218-A | Environmental attributes of the care composition ingredients | 巴斯夫欧洲公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116763963-A | Spiro compounds as malodor counteracting ingredients | 弗门尼舍有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-111432851-B | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-0268198-B1 | FERROELECTRIC LIQUID CRYSTALS | F. HOFFMANN-LA ROCHE AG (CH) | 1993-09-01 | — | — | EP | disclosed |
| EP-0486011-A2 | Pharmaceutical composition against Pneumocystis carinii | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-05-20 | — | — | EP | disclosed |
| EP-0462531-A2 | Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-12-27 | — | — | EP | disclosed |
| US-5013476-A | Ferroelectric properties, electro-optical indicating device | HOFFMANN-LA ROCHE INC. (US) | 1991-05-07 | — | — | US | disclosed |
| US-4960906-A | Process for the preparation of lactones from higher alkenols | SHELL OIL COMPANY (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0341773-A1 | Process for the preparation of lactones | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-11-15 | — | — | EP | disclosed |
| EP-0268198-A2 | Ferroelectric liquid crystals | F. HOFFMANN-LA ROCHE AG (CH) | 1988-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002571-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | ELOVL1, SCD, ELOVL3 | ALDH1A1 1527/4885F7 144/4885F3 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.